Symptoms
Common signs and symptoms of Carbapenem-Resistant Enterobacteriaceae (CRE) include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Carbapenem-Resistant Enterobacteriaceae (CRE).
CRE develops when normal Enterobacteriaceae bacteria acquire genes that allow them to produce enzymes capable of breaking down carbapenem antibiotics.
CRE develops when normal Enterobacteriaceae bacteria acquire genes that allow them to produce enzymes capable of breaking down carbapenem antibiotics. These resistance genes can be passed between bacteria through small DNA pieces called plasmids, allowing resistance to spread rapidly through bacterial populations. The most common resistance mechanisms involve carbapenemase enzymes that literally chew up the antibiotic molecules before they can kill the bacteria.
The widespread use and misuse of antibiotics in healthcare settings, agriculture, and community settings has created selective pressure that favors resistant bacteria.
The widespread use and misuse of antibiotics in healthcare settings, agriculture, and community settings has created selective pressure that favors resistant bacteria. When antibiotics kill off susceptible bacteria, resistant strains have more space and resources to multiply. Hospitals and long-term care facilities become reservoirs for CRE because patients frequently receive multiple courses of broad-spectrum antibiotics, and bacteria can easily spread between patients through contaminated medical equipment or healthcare worker hands.
International travel and global trade have accelerated CRE spread, as resistant bacteria first emerged in certain geographic regions before spreading worldwide.
International travel and global trade have accelerated CRE spread, as resistant bacteria first emerged in certain geographic regions before spreading worldwide. Some countries have higher rates of CRE due to different antibiotic prescribing practices or infection control standards. Once CRE becomes established in a healthcare facility, it can persist in the environment and continue infecting vulnerable patients for months or years if not properly controlled.
Risk Factors
- Recent hospitalization or long-term care facility stay
- Previous treatment with carbapenem or other broad-spectrum antibiotics
- Presence of invasive medical devices like ventilators or catheters
- Recent surgery or invasive medical procedures
- Compromised immune system from illness or medications
- Chronic kidney disease requiring dialysis
- Recent international travel, especially to high-CRE regions
- Advanced age, particularly over 65 years
- Prolonged antibiotic treatment for other infections
- Severe underlying medical conditions like cancer or diabetes
Diagnosis
How healthcare professionals diagnose Carbapenem-Resistant Enterobacteriaceae (CRE):
- 1
Diagnosing CRE infections requires collecting samples from the suspected infection site and growing the bacteria in laboratory culture.
Diagnosing CRE infections requires collecting samples from the suspected infection site and growing the bacteria in laboratory culture. Blood cultures are drawn if doctors suspect bloodstream infection, while urine, sputum, or wound samples may be collected depending on symptoms. Standard bacterial cultures can take 24-48 hours to grow, after which specialized antibiotic sensitivity testing determines whether the bacteria are resistant to carbapenems and other antibiotics.
- 2
Laboratories use specific testing methods to confirm carbapenem resistance and identify the exact resistance mechanisms involved.
Laboratories use specific testing methods to confirm carbapenem resistance and identify the exact resistance mechanisms involved. This information helps doctors choose the most effective available treatments. Some hospitals also perform rapid molecular tests that can detect certain CRE genes within hours, allowing for faster diagnosis and treatment decisions. Rectal screening cultures may be performed on high-risk patients to detect CRE colonization even when no active infection is present.
- 3
Doctors must distinguish CRE infections from other serious bacterial infections based on clinical presentation, patient risk factors, and laboratory results.
Doctors must distinguish CRE infections from other serious bacterial infections based on clinical presentation, patient risk factors, and laboratory results. The diagnosis becomes more challenging when patients have been receiving antibiotics that might interfere with bacterial growth in cultures. In some cases, doctors may need to start treatment based on clinical suspicion while waiting for definitive culture results, especially in critically ill patients.
Complications
- CRE infections carry extremely high complication rates due to limited treatment options and the severity of infections they typically cause.
- Bloodstream infections have mortality rates approaching 50%, while pneumonia caused by CRE can lead to respiratory failure requiring mechanical ventilation.
- Patients may develop septic shock, a life-threatening condition where the body's response to infection causes dangerous drops in blood pressure and organ dysfunction.
- Multiple organ failure affecting the kidneys, liver, and heart can occur rapidly in severe cases.
- Long-term complications affect survivors of serious CRE infections, including prolonged weakness, cognitive difficulties, and increased susceptibility to future infections.
- Some patients require extended rehabilitation after surviving CRE sepsis or pneumonia.
- The antibiotics used to treat CRE infections can cause their own complications, including kidney damage, hearing loss, and peripheral nerve damage that may be permanent.
- Healthcare-associated CRE infections often extend hospital stays significantly, increasing risks of other complications like blood clots, pressure sores, and hospital-acquired pneumonia from other bacteria.
Prevention
- Asking healthcare providers about infection control measures during hospital stays
- Ensuring proper hand hygiene before eating or touching the face during healthcare visits
- Following all post-surgical care instructions carefully
- Reporting any concerning symptoms promptly to healthcare providers
- Staying up to date with vaccinations to prevent infections that might require antibiotic treatment
- Maintaining good overall health through proper nutrition and management of chronic conditions
Treating CRE infections presents enormous challenges because these bacteria resist most available antibiotics.
Treating CRE infections presents enormous challenges because these bacteria resist most available antibiotics. Doctors typically need to use combination therapy with multiple antibiotics to have any chance of success. Common treatment combinations include polymyxins with tigecycline, aminoglycosides, or fosfomycin, though these older antibiotics often have significant side effects and limited effectiveness. Treatment decisions must balance the potential benefits against serious risks of kidney damage, nerve toxicity, and other complications.
Several newer antibiotics have been developed specifically to combat CRE infections.
Several newer antibiotics have been developed specifically to combat CRE infections. Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam can overcome some types of carbapenem resistance and offer improved treatment options for certain CRE strains. However, bacteria can develop resistance to these newer agents as well, and not all CRE infections respond to them. Infectious disease specialists typically guide treatment decisions based on the specific resistance mechanisms identified in laboratory testing.
Supportive care plays a crucial role in CRE treatment, as patients often develop severe complications like septic shock, respiratory failure, or kidney dysfunction.
Supportive care plays a crucial role in CRE treatment, as patients often develop severe complications like septic shock, respiratory failure, or kidney dysfunction. Critical care management may include mechanical ventilation, dialysis, medications to support blood pressure, and careful fluid management. Removing or replacing infected medical devices like catheters or prosthetic materials is often necessary for treatment success, though this may not always be possible in critically ill patients.
Researchers continue developing new treatment approaches, including combination therapies with older antibiotics, novel drug delivery methods, and experimental treatments like bacteriophage therapy.
Researchers continue developing new treatment approaches, including combination therapies with older antibiotics, novel drug delivery methods, and experimental treatments like bacteriophage therapy. Clinical trials are testing promising new antibiotics and treatment combinations, though the approval process takes years. In the meantime, prevention remains far more effective than treatment, emphasizing the importance of infection control measures and appropriate antibiotic use.
Living With Carbapenem-Resistant Enterobacteriaceae (CRE)
Living after a CRE infection requires ongoing medical monitoring and careful attention to preventing future infections. Survivors often need regular follow-up appointments to monitor for long-term complications and assess recovery progress. Some people may continue carrying CRE bacteria in their intestines for months or years after infection, requiring special precautions during future healthcare encounters. Healthcare providers need to know about previous CRE infections to implement appropriate isolation measures and antibiotic choices.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 19, 2026v1.0.0
- Published by DiseaseDirectory